Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE MiR-1-3p was significantly down-regulated in BC tissues and cell lines, while BDNF was significantly up-regulated compared to normal samples. 29322793 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE The methylation status of CpG islands was involved in the regulation of miR-1-3p expression. miR-1-3p inhibited the bladder cancer cell proliferation, migration, and invasion by directly targeting the 3'-UTR of glutaminase. 30458442 2018
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE Bladder cancer tissues had lower levels of miR-1-3p but higher levels of CCL2 than normal tissues ( p < 0.05). 28618950 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 Biomarker disease BEFREE RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1. 28553126 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE MiR-1-3p up-regulates SFRP1 expression in bladder cancer cells, and the over-expression of miR-1-3p can suppress the proliferation, invasion and migration ability of bladder cancer cells. 28268231 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 Biomarker disease BEFREE This study provides evidence for hsa-miR-1 to play tumor suppressive roles via downregulating lncRNA UCA1 in bladder cancer, which may have potential therapeutic significance. 25015192 2014
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE Expression of miR-1, miR-133 and miR-218 was greatly decreased in bladder cancer than normal bladder tissue. 23442927 2013
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE In this study, we focused on splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) on the basis of our previous genome-wide gene expression analysis using miR-1-transfected BC cell lines because putative target sites of miR-1 are existed in 3'-untranslated region (UTR) of SRSF9 mRNA. 22178073 2012
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 Biomarker disease BEFREE Our data indicate that LASP1 may have an oncogenic function and that it might be regulated by miR-1, miR-133a, and miR-218, which may function as tumor suppressive miRNAs in BC. 20843712 2012
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 Biomarker disease BEFREE Tumor suppressive miR-1 and miR-133a-mediated novel molecular targets may provide new insights into the potential mechanisms of BC oncogenesis. 22378464 2012
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.100 AlteredExpression disease BEFREE The downregulation of miR-1 and miR-133a was a frequent event in BC, and these miRNAs were recognised as tumour suppressive. 21304530 2011